BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 29783403)

  • 1. Genetic Alliance Registry and BioBank: a novel disease advocacy-driven research solution.
    Terry SF; Horn EJ; Scott J; Terry PF
    Per Med; 2011 Mar; 8(2):207-213. PubMed ID: 29783403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advocacy groups as research organizations: the PXE International example.
    Terry SF; Terry PF; Rauen KA; Uitto J; Bercovitch LG
    Nat Rev Genet; 2007 Feb; 8(2):157-64. PubMed ID: 17230202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Landscape analysis of registries and biobanks: a tool for disease advocacy organizations to enhance translational research systems.
    Horn EJ; Bialick JF; Terry SF
    Biopreserv Biobank; 2010 Jun; 8(2):115-7. PubMed ID: 24845940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCC6 and Pseudoxanthoma Elasticum: The Face of a Rare Disease from Genetics to Advocacy.
    Moitra K; Garcia S; Jaldin M; Etoundi C; Cooper D; Roland A; Dixon P; Reyes S; Turan S; Terry S; Dean M
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28696355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The melanoma research alliance: the power of patient advocacy to accelerate research and novel therapies.
    Black D; Brockway-Lunardi L
    Cancer Immunol Res; 2013 Dec; 1(6):357-61. PubMed ID: 24778128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry.
    Woodward L; Johnson S; Walle JV; Beck J; Gasteyger C; Licht C; Ariceta G;
    Orphanet J Rare Dis; 2016 Nov; 11(1):154. PubMed ID: 27871301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How disease advocacy organizations participate in clinical research: a survey of genetic organizations.
    Landy DC; Brinich MA; Colten ME; Horn EJ; Terry SF; Sharp RR
    Genet Med; 2012 Feb; 14(2):223-8. PubMed ID: 22261756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beaumont health system biobank: a multidisciplinary biorepository and translational research facility.
    Akervall J; Pruetz BL; Geddes TJ; Larson D; Felten DJ; Wilson GD
    Biopreserv Biobank; 2013 Aug; 11(4):221-8. PubMed ID: 24845589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Minimum Data Set for Sharing Biobank Samples, Information, and Data: MIABIS.
    Norlin L; Fransson MN; Eriksson M; Merino-Martinez R; Anderberg M; Kurtovic S; Litton JE
    Biopreserv Biobank; 2012 Aug; 10(4):343-8. PubMed ID: 24849882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P; Antao V; Kaye W; Sanchez M; Williamson D; Bryan L; Muravov O; Horton K; ;
    MMWR Suppl; 2014 Jul; 63(7):1-14. PubMed ID: 25054277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
    Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
    MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of biobanking in urology: a review.
    Chalfin HJ; Fabian E; Mangold L; Yeater DB; Pienta KJ; Partin AW
    BJU Int; 2016 Dec; 118(6):864-868. PubMed ID: 27469064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Norwegian Multiple Sclerosis Registry and Biobank.
    Myhr KM; Grytten N; Aarseth JH
    Acta Neurol Scand Suppl; 2012; (195):20-3. PubMed ID: 23278652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community participation: a "must" for enabling HIV / AIDS prevention in Africa to "move beyond awareness raising".
    Orr K; Lee S; Edstrom J
    AIDS Anal Afr; 1997 Dec; 7(6):13-5. PubMed ID: 12348321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges.
    Labib RM; Mostafa MM; Alfaar AS; Yehia D; Alaa M; Elzayat MG; Adel M; Ezzat S; Abo El-Naga S
    Biopreserv Biobank; 2016 Feb; 14(1):9-16. PubMed ID: 26691960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Biobank Economic Modeling Tool (BEMT): Online Financial Planning to Facilitate Biobank Sustainability.
    Odeh H; Miranda L; Rao A; Vaught J; Greenman H; McLean J; Reed D; Memon S; Fombonne B; Guan P; Moore HM
    Biopreserv Biobank; 2015 Dec; 13(6):421-9. PubMed ID: 26697911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform.
    Nurok M; Eslick I; Carvalho CR; Costabel U; D'Armiento J; Glanville AR; Harari S; Henske EP; Inoue Y; Johnson SR; Lacronique J; Lazor R; Moss J; Ruoss SJ; Ryu JH; Seyama K; Watz H; Xu KF; Hohmann EL; Moss F
    Lymphat Res Biol; 2010 Mar; 8(1):81-7. PubMed ID: 20235890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a network-based intra-hospital virtual cancer biobank.
    Zhang L; Wu X; Hu Y; Wang X; He Z; Xie Y; Pan K; Wang N; Dong Z; Zhang L; Ji J
    Biopreserv Biobank; 2015 Feb; 13(1):43-8. PubMed ID: 25686047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with a rheumatoid arthritis biobank: analysis of biological samples and clinical data of 204 patients].
    Pál I; Pusztai A; Csomor P; Szekanecz Z
    Orv Hetil; 2017 Feb; 158(7):270-277. PubMed ID: 28462625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods to Improve Sustainability of a Large Academic Biorepository.
    Kelly SM; Wiehagen LT; Schumacher PE; Dhir R
    Biopreserv Biobank; 2017 Feb; 15(1):31-36. PubMed ID: 27860489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.